RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mersana Therapeutics - Stock

Mersana Therapeutics Revenue 2024

Mersana Therapeutics Revenue

40.49 M USD

Mersana Therapeutics Dividend yield

Ticker

MRSN

ISIN

US59045L1061

WKN

A2DTR7

In 2024, Mersana Therapeutics's sales reached 40.49 M USD, a 9.86% difference from the 36.86 M USD sales recorded in the previous year.

The Mersana Therapeutics Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2030e559.6-
2029e530.93-
2028e205.6-
2027e31.73-
2026e33.15-
2025e32.61-
2024e40.49-
202336.86-
202226.58-
20210.04-
20200.83-
201942.12-
201810.59-
201717.55-
201625.17-
201510.36-

Mersana Therapeutics Aktienanalyse

What does Mersana Therapeutics do?

Mersana Therapeutics Inc is a biotechnology company based in Cambridge, Massachusetts, USA. Founded in 2001, the company focuses on developing novel targeted cancer therapies based on the innovative Targeted Payload Apex platform. The company's pipeline includes multiple product candidates in various stages of clinical development, including XMT-1536 and XMT-1592. Mersana Therapeutics Inc collaborates with leading oncologists, scientists, and research institutes to advance its technologies and develop high-quality, safe, and effective therapies for cancer patients. The company's business model is based on utilizing its technology platform and product discovery capabilities to develop novel drugs. It is divided into different business areas targeting different medical applications, including oncology, ophthalmology, immunology, and metabolic diseases. Mersana Therapeutics Inc aims to improve the efficacy, safety, and tolerance of cancer therapies and meet the unmet medical need for targeted cancer treatments. Mersana Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Mersana Therapeutics's Sales Figures

The sales figures of Mersana Therapeutics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Mersana Therapeutics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Mersana Therapeutics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Mersana Therapeutics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Mersana Therapeutics Stock

How much revenue did Mersana Therapeutics generate this year?

Mersana Therapeutics has achieved a revenue of 40.49 M USD this year.

How much was the turnover of the company Mersana Therapeutics compared to the previous year?

The revenue of Mersana Therapeutics has increased by 9.86% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Mersana Therapeutics?

The revenue of Mersana Therapeutics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Mersana Therapeutics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Mersana Therapeutics so important for investors?

The revenue of Mersana Therapeutics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Mersana Therapeutics pay?

Over the past 12 months, Mersana Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mersana Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Mersana Therapeutics?

The current dividend yield of Mersana Therapeutics is .

When does Mersana Therapeutics pay dividends?

Mersana Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mersana Therapeutics?

Mersana Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Mersana Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mersana Therapeutics located?

Mersana Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mersana Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mersana Therapeutics from 6/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.

When did Mersana Therapeutics pay the last dividend?

The last dividend was paid out on 6/7/2024.

What was the dividend of Mersana Therapeutics in the year 2023?

In the year 2023, Mersana Therapeutics distributed 0 USD as dividends.

In which currency does Mersana Therapeutics pay out the dividend?

The dividends of Mersana Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Mersana Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Mersana Therapeutics

Our stock analysis for Mersana Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mersana Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.